Serotonergic hallucinogens/psychedelics could be promising treatments for depressive and anxiety disorders in end-stage cancer. October 28, 2019
The Psilocybin-Telomere Hypothesis: An Empirically Falsifiable Prediction Concerning the Beneficial Neuropsychopharmacological Effects of Psilocybin on Genetic Aging September 24, 2019
Psilocybin-assisted mindfulness training modulates self-consciousness and brain default mode network connectivity with lasting effects August 1, 2019
Classical psychedelics for the treatment of depression and anxiety: A systematic review. July 30, 2019
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research. July 14, 2019
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory July 11, 2019
